NDC00173-0369-32: CEPHALOTHIN FOR INJECTION.
The CEPHALOTHIN FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: POWDER, administration: INTRAVENOUS, special_features: EA INFUSION BOTTLE HAS A 100 ML CAPACITY, primary_container_type: BOTTLE, INFUSION, supplementary_features: MEDSEP ITEM FOR DOD,GLAXO INC, secondary_container_type: TRAY. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-238-5627, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| administration | INTRAVENOUS |
| special_features | EA INFUSION BOTTLE HAS A 100 ML CAPACITY |
| primary_container_type | BOTTLE, INFUSION |
| supplementary_features | MEDSEP ITEM FOR DOD,GLAXO INC |
| secondary_container_type | TRAY |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 100 |
| primary_container_content_quantity | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| total_secondary_container_quantity | 10 |
| active_medicament_medicinal_strength | 2.000 GRAMS CEPHALOTHIN EQUIVALENT G |
| primary_container_quantity_per_secondary_container | 10 TRAY |
| NSN | 6505-01-238-5627 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| SUPPLEMENTARY FEATURES | MEDSEP ITEM FOR DOD,GLAXO INC |
| SECONDARY CONTAINER TYPE | TRAY |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE, INFUSION |
| PHYSICAL FORM | POWDER |
| SPECIAL FEATURES | EA INFUSION BOTTLE HAS A 100 ML CAPACITY |
| TOTAL SECONDARY CONTAINER QUANTITY | 10 |
| PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER | 10 TRAY |